< Back to latest news & events

Event

4th Microbiome: Recent Developments, Regulatory, Quality and Commercialization Summit

October 2020

Event date: 15th October 2020

HGF Partner Craig Thomson will be speaking at the 4th Microbiome: Recent Developments, Regulatory, Quality and Commercialization Summit on 15th October.

The Summit will shed light on current challenges, best practices, and inside views of the future of microbiome-based products in relation to the quality, safety, and efficiency.

The speakers will discuss key findings, critical insights, and recommendations for driving efficient strategies within the microbiome landscape.

HGF Partner Craig Thomson will be presenting on Thursday 15th October.

Microbiome and IP – How to Build a Commercially Relevant Patent Portfolio

For any Microbiome Innovator, there are many combinations of reasons to consider building an IP Portfolio: to protect a monopoly of sales for your product or service, to enhance valuation of your company for sale, to enhance your bargaining position with a collaborator or competitor, or to form part of the package designed to attract investors. No matter the reason, or combinations of reasons, a coherent IP strategy that recognises the specific timelines and commercial goals of your company is vital. Using the International IP systems to protect many of the innovations in the microbiome field has very specific challenges; adding another burden to the job of creating of an appropriate IP strategy. Indeed, an important part of such a strategy is the consideration of when not to protect by registered IP rights. Craig will provide a road-map of actions to be taken and considered when developing such strategies for a Microbiome innovator.

Attendees

Latest updates

IP Ingredients Blog, Parts 11-20

Welcome to our blog series, IP Ingredients, created by our Food & Drink Team. This blog will explore the latest IP news, updates, and discussions in the food & drink …

Read article

EnteroBiotix Limited Secures £27m Financing Round to Advance Clinical Trials

We are pleased to congratulate EnteroBiotix, on their milestone in their journey towards revolutionising healthcare for patients battling gut-related ailments. The leading clinical-stage biotechnology company has successfully closed a £27 …

Read article
Event - 20th June 2024

Go:Tech Awards 2024 shortlist has been revealed

The shortlist has now been revealed for the Go:Tech 2024 awards, which will take place on the 20th June in London. We are delighted to be sponsoring the ‘Tech Start-Up …

Event details

HGF wins big at the Managing IP EMEA Awards Ceremony 2024

The Annual Managing IP Awards: EMEA Awards 2024 were announced last night, and HGF are proud to have won ‘Ireland Patent Prosecution Firm of the Year’ and ‘Netherlands Trademark Prosecution …

Read article

IP Ingredients, Part 11: Exploring colours in the food & drink sector – a patent perspective

As the saying goes, “We eat first with our eyes”. The visual appearance, especially the colour, of a food or beverage product is one of the first things that a …

Read article

Digital Health in 2023: Exploring Europe's Patent Innovations

The EPO recently published its 2023 Patent Index and there is, as seen in 2022, further increased patenting activity in key technologies relevant to the healthcare sector. Spurred by the …

Read article